Protective mechanism of Lygodium flexuosum extract in treating and preventing carbon tetrachloride induced hepatic fibrosis in rats

Chemico-Biological Interactions

Volumn 165, Issue 1, 2007, Pages 76-85

  Wills, P J ^a   Asha, V V ^a  

^a RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY   (India)

Author keywords

Carbon tetrachloride; IL 1 ; Lygodium flexuosum; MMP 13; Procollagen I; Procollagen III; TGF 1; TIMP 1; TNF

Indexed keywords

CARBON TETRACHLORIDE; COLLAGEN TYPE 3; COLLAGENASE 3; COMPLEMENTARY DNA; INTERLEUKIN 1BETA; LYGODIUM FLEXUOSUM EXTRACT; MESSENGER RNA; PLANT EXTRACT; PROCOLLAGEN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INDIA; LIVER FIBROSIS; LIVER TOXICITY; LYGODIUM FLEXUOSUM; MALE; MEDICINAL PLANT; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RAT; TRADITIONAL MEDICINE; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARBON TETRACHLORIDE POISONING; FERNS; LIVER CIRRHOSIS; MALE; MATRIX METALLOPROTEINASE 13; PLANT EXTRACTS; PROCOLLAGEN; PROTECTIVE AGENTS; RATS; RATS, WISTAR; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1;

LYGODIUM FLEXUOSUM; RATTUS NORVEGICUS;

EID: 33845637943     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2006.10.010     Document Type: Article

References (29)

1. Tsukada S., Parsons C.J., and Rippe R.A. Mechanisms of liver fibrosis. Clin. Chim. Acta 364 (2006) 33-60
2. Bruck R., Genina O., Aeed H., Alexiev R., Nagler A., Avni Y., and Pines M. Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats. Hepatology 33 (2001) 379-386
3. Campo G.M., Avenoso A., Campo S., D'Ascola A., Ferlazzo A.M., and Calatroni A. The antioxidant and antifibrogenic effects of the glycosaminoglycans hyaluronic acid and chondroitin-4-sulphate in a subchronic rat model of carbon tetrachloride-induced liver fibrogenesis. Chem. Biol. Interact. 148 (2004) 125-138
4. Bataller R., and Brenner D.A. Liver fibrosis. J. Clin. Invest. 115 (2005) 209-218
5. Lee S.H., Nan J.X., Zhao Y.Z., Woo S.W., Park E.J., Kang T.H., Seo G.S., Kim Y.C., and Sohn D.H. The chalcone butein from Rhus verniciflua shows antifibrogenic activity. Planta Med. 69 (2003) 990-994
6. Tasduq S.A., Mondhe D.M., Gupta D.K., Baleshwar M., and Johri R.K. Reversal of fibrogenic events in liver by Emblica officinalis (fruit), an Indian natural drug. Biol. Pharm. Bull. 28 (2005) 1304-1306
7. Yao X.X., Jiang S.L., Tang Y.W., Yao D.M., and Yao X. Efficacy of Chinese medicine Yi-gan-kang granule in prophylaxis and treatment of liver fibrosis in rats. World J. Gastroenterol. 11 (2005) 2583-2590
8. Shahjahan M., Vani G., and Shyamaladevi C.S. Effect of Solanum trilobatum on the antioxidant status during diethyl nitrosamine induced and phenobarbital promoted hepatocarcinogenesis in rat. Chem. Biol. Interact. 156 (2005) 113-123
9. Inao M., Mochida S., Matsui A., Eguchi Y., Yulutuz Y., Wang Y., Naiki K., Kakinuma T., Fujimori K., Nagoshi S., and Fujiwara K. Japanese herbal medicine Inchin-ko-to as a therapeutic drug for liver fibrosis. J. Hepatol. 41 (2004) 584-591
10. Sakaida I., Hironaka K., Kimura T., Terai S., Yamasaki T., and Okita K. Herbal medicine Sho-saiko-to (TJ-9) increases expression matrix metalloproteinases (MMPs) with reduced expression of tissue inhibitor of metalloproteinases (TIMPs) in rat stellate cell. Life Sci. 74 (2004) 2251-2263
11. Jain S.K. Dictionary of Indian Folk Medicine and Ethnobotany (1991), Deep Publications, New Delhi p. 120
12. Henry A.N., Hosagoudar V.B., and Ravikumar K. Ethno-medico-botany of the Southern Western Ghats of India. In: Jain S.K. (Ed). Ethnobiology in Human Welfare: Proceedings of IV International Congress of Ethnobiology. Lucknow, India, November 17-21, 1994, Deep Publications, New Delhi (1996) 173-180
13. Kumar K. Notable pertinence of Lygodium flexuosum (L.) Sw. in tribal medicine of India: an ethnopharmacognostical investigation. In: Govil J.N., and Singh V.K. (Eds). Recent Progress in Medicinal Plants. vol I. Ethnomedicine and Pharmacognosy (2002), SCI Tech Publishing LLC, Texas 315-323
14. Wills P.J., and Asha V.V. Preventive and curative effect of Lygodium flexuosum (L.) Sw. on carbon tetrachloride induced hepatic fibrosis in rats. J. Ethnopharmacol. 107 (2006) 7-11
15. Wills P.J., and Asha V.V. Protective effect of Lygodium flexuosum (L.) Sw. (Lygodiaceae) against d-galactosamine induced liver injury in rats. J. Ethnopharmacol. 108 1 (2006) 116-123
16. Wasser S., Ho J.M., Ang H.K., and Tan C.E. Salvia miltiorrhiza reduces experimentally-induced hepatic fibrosis in rats. J. Hepatol. 29 (1998) 760-771
17. 4-induced cirrhosis. Am. J. Physiol. 277 (1999) G838-G846
18. Simeonova P.P., Gallucci R.M., Hulderman T., Wilson R., Kommineni C., Rao M., and Luster M.I. The role of tumor necrosis factor-alpha in liver toxicity, inflammation, and fibrosis induced by carbon tetrachloride. Toxicol. Appl. Pharmacol. 177 (2001) 112-120
19. Mancini R., Benedetti A., and Jezequel A.M. An interleukin-1 receptor antagonist decreases fibrosis induced by dimethylnitrosamine in rat liver. Virchows Arch. 424 (1994) 25-31
20. Milani S., Herbst H., Schuppan D., Surrenti C., Riecken E.O., and Stein H. Cellular localization of type I III and IV procollagen gene transcripts in normal and fibrotic human liver. Am. J. Pathol. 137 (1990) 59-70
21. Iredale J.P. Tissue inhibitors of metalloproteinases in liver fibrosis. Int. J. Biochem. Cell. Biol. 29 (1997) 43-54
22. Arthur M.J., Iredale J.P., and Mann D.A. Tissue inhibitors of metalloproteinases: role in liver fibrosis and alcoholic liver disease. Alcohol Clin. Exp. Res. 23 (1999) 940-943
23. Le J., and Vilcek J. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab. Invest. 56 (1987) 234-248
24. Montes A.S., Rizo V.D., and Borunda J.A. Differential gene expression of proinflammatory and anti-inflammatory cytokines in acute and chronic liver injury. Hepatol. Res. 16 (2000) 181-194
25. Kolb M., Margetts P.J., Anthony D.C., Pitossi F., and Gauldie J. Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J. Clin. Invest. 107 (2001) 1529-1536
26. Gressner A.M., Weiskirchen R., Breitkopf K., and Dooley S. Roles of TGF-beta in hepatic fibrosis. Front. Biosci. 7 (2002) d793-d807
27. 4-induced liver fibrosis in rats. World J. Gastroenterol. 10 (2004) 1037-1042
28. Yoshiji H., Kuriyama S., Miyamoto Y., Thorgeirsson U.P., Gomez D.E., Kawata M., Yoshii J., Ikenaka Y., Noguchi R., Tsujinoue H., Nakatani T., Thorgeirsson S.S., and Fukui H. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model. Hepatology 32 (2000) 1248-1254
29. Wills P.J., and Asha V.V. Protective effect of Lygodium flexuosum (L.) Sw. extract against carbon tetrachloride-induced acute liver injury in rats. J. Ethnopharmacol. 108 3 (2006) 320-326